Ligand Pharmaceuticals Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: San Diego CA United States (1987)

Organization Overview

First Clinical Trial
1995
NCT00050999
First Marketed Drug
1999
alitretinoin (panretin)
First NDA Approval
1999
alitretinoin (panretin)
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Ligand Pharmaceuticals